Cyanotech Corporation

CYAN ·Healthcare, Drug Manufacturers - General, United States
Valuation › AI Valuation

AI Valuation

AI-generated fair value estimate for this company.

AI Fair Value $0.52
Market Price $0.41
Undervalued By 21.2%

Method: 10-year unlevered FCF DCF: $0.3M normalized FCF base (near-breakeven); 4% growth years 1-5; 2% years 6-10; 14% discount rate; 2% terminal growth; $1.0M estimated net cash; 7.25M shares outstanding.

Reasoning: Cyanotech is a small, mature algae-based nutraceutical producer with slim margins and modest growth; a low-growth DCF with an elevated discount rate (reflecting small-cap/thin-liquidity risk) fits its stagnant but still slightly cash-generative profile.